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Preimplantation Genetic Diagnosis for Cystic Fibrosis 
Laia Comas Fages Genetics degree, Autonomous University of Barcelona  
Preimplantation genetic diagnosis (PGD), is a technique used to identify genetic defects in embryos created through in vitro fertilization before pregnancy. Since only unaffected embryos are transferred to the
uterus for implantation, PGD provides an alternative to prenatal procedures. But it was not until 1989 in London that the first unaffected child was born with a successfully PGD cycle. Even though cystic fibrosis (CF) was the first
monogenic disorder to accomplish a successful PGD cycle, it was not until 1992 that they succeeded. Nowadays this technique is practiced worldwide, one of the challenges that PGD had to undertake was that only one cell is available
for the diagnosis. The purpose of this review is to understand cystic fibrosis as well as to comprehend the techniques that made PGD possible, through the years up to the present time.
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Cystic fibrosis is an autosomal recessive chronic
disease. It causes thick and sticky mucus to build up in the
lungs, digestive tract and other areas of the body.
More than 1.900 mutations in the CFTR gene
(Cystic Fibrosis Transmembrane Conductance Regulator) 
Milder
mutations
↑Frequent and 
↑deleterious mutation in 
the Caucasian population
CFTR – Related Disorders
The symptoms and the severity of the
disease can vary widely among patients.
1986 The consensus view was that the blastocyst biopsy was the most likely to succeed.
Diagnostic Methods History and Present
Causes of Variability in Outcomes
Typically:
∆F508 with 
R117H or
IVS8-5T  
Congenital bilateral 
absence of the vas 
deferens (CBAVD) 
Acute or recurrent  
chronic pancreatitis 
Disseminated 
bronchiectasis
1989 An approach was determined, valuable for couples at risk of transmitting
X-linked diseases. The sex was determined with a Y specific probe.
1990
This year were reported the first established pregnancies using PGD, in two couples known  to be 
at risk of transmitting adrenoleukodystrophy an X-linked mental retardation.
1992
Using the polymerase chain reaction (PCR) with nested primers, a normal fragment of 154pb from 
the CFTR gene was amplified, this fragment included the ∆F508 region (151pb).
First healthy girl (from embryo 2) born free of Cystic Fibrosis  through PGD. 
Embryos that could be transferred:
Healthy non carrier embryo.
Healthy  embryo (but ∆F508 carrier). 
Key of the technique:
The migration of the DNA
heteroduplex is retarded.
1994 First time with PGD for Cystic Fibrosis.. 
Men with CF usually 
have CBAVD 
Microsurgical epididymal sperm 
aspiration (MESA) was 
performed to obtain 
spermatozoa
Epididymis
Intracytoplasmatic
sperm injection
1995
Two-round PCR 
amplification
- Common mutations.
- Severe phenotypes:
WW,  ΔΔ and WΔ.
W1282X (W) 
ΔF508 (Δ) Nested PCR separately 
(at each locus)
Multiplex PCR 
1998
Aspiration method 
Use of Tyrode's acid solution
Cell obtaining methodology.. Use of a diode 
noncontact laser
(reduced embryo viability)
Quicker, simpler and safer.
Well-defined hole. 
Introduction
There was a need to detect more than 1 mutation from one blastomere...
Multiplex marker PCR protocol, with four
closely linked highly polymorphic markers.
Allelic drop out(ADO) and the presence of additional alleles
(AA) indicated that the PCR results may not be reliable.
This protocol could be applicable to 87% of the couples carrying a CFTR mutation.
In 91% of the cases at least one partner of the
couple carries the ∆F508 mutation.
This strategy was based on a multiplex fluorescent
PCR co-amplifying the ∆F508 mutation and two
CFTR intragenic polymorphic microsatellites
(IVS8CA and IVS17bCA).
↓The risk of 
misdiagnosis due to 
meiotic recombination
The use of 
intragenic markers
v
ADO
AA
Four intragenic polymorphic repeats identified: IVS1CA, IVS8CA, IVS17bTA and IVS17bCA.
A procedure was validated for the
seven microsatellites in a single run,
which detects approximately 90% of
the mutant alleles.
Consequently, 1 or both causal
mutations were unknown in about
20% of the cases.
Three novel polymorphic repeats were identified:
IVS3polyA, IVS4polyA, IVS10CA.
2000
2002
2009
2013
The disease
In the majority of the cases 
linkage analysis is performed.
Fluorescent in situ hybridization (FISH) is also used in 
order to assure no chromosomal abnormalities. 
Single cell amplification could be undertook by nested – PCR,
fluorescent – PCR, multiplex – PCR or a combination of them.
Nowadays the PCR sensitivity is 99.2% and its specificity is 80.9%, however the accuracy is
statistically higher when PGD is performed on two cells and multiplex protocols are applied.
Conclusions and future developments  
Even though the validity, robustness and high diagnostic value of PCR-based PGD has been
demonstrate, the wide range of mutations for CF and CFTR – Related Disorders are still a problem for
assuring the identification of both embryonic alleles.
Low throughput
Time consuming
Diagnostic rate of 98.91%
↓Time ↓Cost
Present time: Molecular methods Future: Next generation sequencing (NGS) technologies 
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